Showing results (171-180 of 193) with videos related to

Sort By:
Pageof 20
Cancer Research Communications|September 15, 2023
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other TumorsGlenn J Hanna, Anastasios Stathis, Elena Lopez-Miranda, et al.
Bone Marrow Transplantation|March 20, 2024
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMTRomain Guièze, Diderik-Jan Eikema, Linda Koster, et al.
Leukemia & Lymphoma|December 12, 2018
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapyJorge Labrador, Elisa Luño, Edo Vellenga, et al.
Cancer|April 24, 2019
Incidence and outcome after first molecular versus overt recurrence in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia included in the ALL Ph08 trial from the Spanish PETHEMA GroupJosep-Maria Ribera, Olga García, María-José Moreno, et al.
Cancers|July 9, 2022
Bone Marrow Stromal Cell Regeneration Profile in Treated B-Cell Precursor Acute Lymphoblastic Leukemia Patients: Association with MRD Status and Patient OutcomeElen Oliveira, Elaine S Costa, Juana Ciudad, et al.
Cancer Medicine|February 6, 2020
A pediatric regimen for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trialJosep-Maria Ribera, Mireia Morgades, Pau Montesinos, et al.
Blood|September 9, 2011
Outcome according to cytogenetic abnormalities and DNA ploidy in myeloma patients receiving short induction with weekly bortezomib followed by maintenanceMaría-Victoria Mateos, Norma C Gutiérrez, María-Luisa Martín-Ramos, et al.
Leukemia & Lymphoma|November 23, 2017
Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemiaJosep-Maria Ribera, Mireia Morgades, Pau Montesinos, et al.
Haematologica|August 10, 2023
Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trialJosep-Maria Ribera, Mireia Morgades, Olga Garcia-Calduch, et al.
Histopathology|September 15, 2022
Genetic and phenotypic characterisation of HIV-associated aggressive B-cell non-Hodgkin lymphomas, which do not occur specifically in this population: diagnostic and prognostic implicationsMaria Joao Baptista, Gustavo Tapia, Ana-María Muñoz-Marmol, et al.
Pageof 20